Impact of Early Optimization of Brain Oxygenation on Neurological Outcome After Severe Traumatic Brain Injury
- Conditions
- Brain Injuries, Traumatic
- Interventions
- Other: No PbtO2 probesDevice: PbtO2 probes
- Registration Number
- NCT02754063
- Lead Sponsor
- University Hospital, Grenoble
- Brief Summary
Post-traumatic brain hypoxia/ischemia develops hours after traumatic brain injury (TBI), and its intensity is directly related to the neurological outcome. The thresholds for irreversible tissue damage following TBI indicate a particular vulnerability of injured brain. Improving brain oxygenation after severe TBI is the focus of modern TBI management in the intensive care unit (ICU).
The calculation of cerebral perfusion pressure (CPP), with CPP = mean arterial pressure (MAP) - intracranial pressure (ICP), has become the most used estimator of cerebral blow flow. To prevent ischemia due to elevated ICP, current international guidelines recommend maintaining CPP at 60-70 mmHg and ICP below 20 mmHg. However, episodes of brain hypoxia/ischemia, as assessed with brain tissue oxygen pressure (PbtO2) measurements, might occur despite optimization of CPP and ICP, and have been independently associated with poorer patient outcome. PbtO2 values lower than 15 mmHg for more than 30 minutes were shown to be an independent predictor of unfavorable outcome and death. The aggressive treatment of low PbtO2 was associated with improved outcome compared to standard ICP/CPP-directed therapy in cohort studies of severely head-injured patients. On the basis of these findings, it is hypothesized that an early optimization of brain oxygenation, together with keeping ICP and CPP within recommended values, could reduce the volume of vulnerable lesions following severe TBI and possibly improve neurological outcome.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 320
- Age between 18 and 75
- Severe non- penetrating TBI (GCS score 3-8) with motor Glasgow score between 1 and 5
- Possible associated extracranial lesions, except tetraplegia
- Initiation of cerebral monitoring within the first 16 hours since primary traumaticinjury
- Indication of ICP monitoring on admission as part of the management
- Indication of continuous sedation/analgesia for more than 48 hours
- Under mechanical ventilation with stable conditions: PaO2//FiO2 over 150 and PaCO2 between 35 and 45 mmHg, mean arterial pressure over 70 mmHg
- Written informed consent from legal surrogate, patient's relative or investigator decision
- Affiliation to the French Social Security or affiliated to a social security system of EU member state, Norway, Lichtenstein, Iceland or Switzerland
- French-speaking or English-speaking patient
- Penetrating TBI
- GCS 3 with bilateral fixed dilated pupils
- Decompressive craniectomy and no repositioning of the bone flap after subdural hematoma evacuation surgery prior to enrolment
- Contraindication of ICP and/or PbtO2 monitoring, i.e., hemostasis disorders and brain tissue infection
- Persistent hemodynamic or respiratory instability despite treatments, i.e., mean arterial pressure < 70 mmHg, PaO2/FiO2 <150, PaCO2 <30 mmHg or >45 mmHg or lactate >5 mmol/l if available.
- Hypothermia <34°C at randomization
- Life expectancy < 24 hours
- Cardiac arrest at initial presentation
- Tetraplegia
- Neuropsychiatric co-morbidities that could interfere with 6 and 12-months assessment outcomes.
- Consent refusal
- Pregnancy
- Participation in another therapeutic study with written consent
- Inability to have a 6-months follow-up
- Ischemic stroke after carotid arterial dissection
- Incapacitated patients in accordance with article L 1121-5 to L1121-8 of the public health code.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description ICP Management No PbtO2 probes - PbtO2 + ICP Management PbtO2 probes -
- Primary Outcome Measures
Name Time Method Neurological outcome according to the extended Glasgow Outcome Scale (GOSE) blind assessed at 6 months post-trauma
- Secondary Outcome Measures
Name Time Method Neurological outcome according to the extended Glasgow Outcome Scale (GOSE) and Disability Rating Scale at 12 months post-trauma (GOSE) Quality of life assessment: Functional Independence Measure (FIM) and Medical Outcomes Study Short-Form 12 (SF-12) at 6 and 12 months post-trauma Disability Rating Scale (DRS) at 6 and 12 months post-trauma Mortality rate at day 28 Therapeutic intensity as reflected by the number of level 2 and level 3 treatments to treat elevated ICP during the first 5 days of the ICU stay Incidence of critical events as defined by: ICP >30 mmHg during 30 min at least ICP >40 mmHg during 5 min at least PbtO2 <10 mmHg during 30 min at least (PbtO2 group) during the first 5 days of the ICU stay
Trial Locations
- Locations (26)
University Hospital of Kremlin-Bicetre
🇫🇷Le Kremlin Bicetre, France
University Hospital of Nimes
🇫🇷Nimes, France
University Hospital of Lille
🇫🇷Lille, France
CHU Angers
🇫🇷Angers, France
General Hospital of Annecy
🇫🇷Annecy, France
University Hospital Besançon
🇫🇷Besançon, France
University Hospital of Bordeaux
🇫🇷Bordeaux, France
CHU CAEN
🇫🇷Caen, France
University Hospital of Clermont-Ferrand
🇫🇷Clermont-Ferrand, France
Grenoble University Hospital
🇫🇷Grenoble, France
University Hospital of Dijon
🇫🇷Dijon, France
University Hospital of Marseille-Timone
🇫🇷Marseille, France
University Hospital of Marseille-Nord
🇫🇷Marseille, France
University Hospital of Lyon
🇫🇷Lyon, France
University Hospital of Nancy
🇫🇷Nancy, France
University Hospital of Nice
🇫🇷Nice, France
University Hospital of Montpellier
🇫🇷Montpellier, France
University Hospital of Paris-Salpetriere
🇫🇷Paris, France
University Hospital of Poitiers
🇫🇷Poitiers, France
University Hospital of Rennes
🇫🇷Rennes, France
University Hospital Sud Réunion
🇫🇷Saint Pierre, France
University Hospital of Rouen
🇫🇷Rouen, France
University Hospital of St-Etienne
🇫🇷Saint-Etienne, France
University Hospital of Toulouse
🇫🇷Toulouse, France
Hôpital d'Instruction des Armées
🇫🇷Toulon, France
University Hospital of Strasbourg
🇫🇷Strasbourg, France